Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bsp017
    Member
    • Jul 2013
    • 16

    #1

    SMRT portal errors

    Hi,

    I'm trying to assemble six SMRT cells de novo on the SMRT portal. I tried HGAP.2 and HGAP.3 but both fail with different errors:

    CeleraAssembler/runCaHgap Failed - for HGAP.2
    AssembleUnitig/runCaToUnitig Failed - for HGAP.3

    I'm running SMRT portal through Amazon Web Services.

    On the PacBio github it provides troubleshooting information for the SMRT pipe but I'm unsure how to access this through AWS.

    Any information on how to troubleshoot this would be much appreciated.

    James
  • rhall
    Senior Member
    • Aug 2012
    • 324

    #2
    They are both essentially the same failure. What size amazon instance are you running, in particular memory?
    This failure will arise if <16gb of memory is available.

    Comment

    • bsp017
      Member
      • Jul 2013
      • 16

      #3
      Its an m3.large instance, with 7.5 GB memory. I guess I need a bigger instance.

      Comment

      • bsp017
        Member
        • Jul 2013
        • 16

        #4
        Hello rhall and others,

        I changed to a m3.2xlarge instance, with 30 GB of RAM and assembled my two genomes into 1 and 3 contigs. They both have a QV score just under 50.

        I uploaded the polished assemblies fasta files to use as a reference and I now want to use the reseqeuncing program to wrap up the assemblies, but when I use this tool I get an error saying: 'Failed to submit job'. The error appears usually after several hours.

        I also get this error when I try the Modification and Motif analysis.

        Is there a way around this?

        Thanks,

        James

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        10 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Working...